N/A N=6,013 Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake
Cervical Intraepithelial Neoplasia
Primary: Screening Uptake — 2519; 0; 2618; 599 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=51 Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Absolute C-reactive Protein (CRP) Values at Day 98 - As Treated Population — 12.85; 14.25; 21.85; 16.60 mg/L
Phase 4 N=161 Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
Skin Diseases, Infectious
Primary: Skin Abscess Resolution — 4; 3 participants
Phase 2 N=121 Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
Macular Edema · Retinal Vein Occlusion
Primary: Change From Baseline at Month 1 in Retinal Thickness in the Study Eye During Stage 1 — 500.2; 495.8; 499.5; 468.3 Microns
N/A N=847 Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
Conjunctivitis, Allergic
Primary: Percentage of Patients Reporting Adverse Events — 0.13 Percentage of Patients
Phase 4 N=252 A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects
Dyslipidemia
Primary: Change of Fasting Serum Low-density Lipoprotein Cholesterol (LDL-C) at 12 Weeks — 155.1; 154.6 mg/dL
Phase 2 N=33 Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer
Prostate Neoplasms
Primary: Phase 1: Maximum Tolerated Dose (MTD) of Abiraterone Acetate — NA mg/day
N/A N=100 A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
Myopia
Primary: Visual Acuity — -0.054; -0.051 LogMAR
N/A N=192 Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2
Myopia · Hyperopia · Contact Lens Comfort
Primary: Subjective Lens Wear Comfort — 4.3; 4.3 units on a scale
N/A N=115 Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Nausea · Vomiting
Primary: Number of Participants With Postoperative Nausea and Vomiting — 28; 34 participants
N/A N=60 Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound
Treatment of Adipose Tissue in the Thighs
Primary: Clinical Improvement in Thigh Circumference — -1.22; -0.59 centimeter
N/A N=50 Evaluation of Enfilcon A Soft Contact Lens When Compared to Galyfilcon A Soft Contact Lens
Ametropia
Primary: Objective Assessment: Ocular Response - Biomicroscopy — 1.00; NA; NA; NA units on a scale
Phase 2 N=62 Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
Brain and Central Nervous System Tumors
Primary: Number of Participants With Dose-limiting Toxicity (DLT) — 0; 0; 1; 2 participants
Phase 4 N=90 Improvement in Pain,Function and HRQoL ( Health Related Quality of Life) in Subacute Low Back Pain: A Controlled Clinical Trial of Exercise vs NSAIDs (Nonsteroidal Antiinflammatory)
Back Pain Lower Back
Primary: Visual Analogue Scale of Pain — 47.3; 45.2 units on a scale
N/A N=115 Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Nausea · Vomiting
Primary: Number of Participants With Nausea and Vomiting — 24; 29 participants